Page 145 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

124 PART II Diagnostic Procedures for the Cancer Patient

76. Krimins RA, Fritz J, Gainsburg LA, et al.: Use of magnetic reso- 98. Lawrence J, Vanderhoek M, radiology DBV, et al.: Uses of
nance imaging-guided biopsy of a vertebral body mass to diagnose 3′‐deoxy‐3′‐[18F]fluorothymidine PET/CT for evaluating
osteosarcoma in a Rottweiler, J Am Vet Med Assoc 250:779–784, response to cytotoxic chemotherapy in dogs with non-Hodgkin’s
VetBooks.ir 77. Nagel KNA, Schouten MG, Hambrock T, et al.: Differentiation 99. Bradshaw TJ, Bowen SR, Deveau MA, et al.: Molecular imaging
lymphoma, Vet Radiol Ultrasound 50:660–668, 2009.
2017.
of prostatitis and prostate cancer by using diffusion-weighted MR
imaging and MR-guided biopsy at 3 T, Radiology 267:164–172, biomarkers of resistance to radiation therapy for spontaneous nasal
tumors in canines, Radiat Oncol Biol 91:787–795, 2015.
2013. 100. Randall EK: PET-computed tomography in veterinary medicine,
78. McConnell JF, Garosi L, Platt SR: Magnetic resonance imaging Vet Clin North Am Small Anim Pract 46:515–533, 2016.
findings of presumed cerebellar cerebrovascular accident in twelve 101. Lowe VJ, Fletcher JW, Gobar L, et al.: Prospective investigation
dogs, Vet Radiol Ultrasound 46:1–10, 2005. of positron emission tomography in lung nodules, J Clin Oncol
79. Garosi L, McConnell JF, Platt SR, et al.: Clinical and topographic 16:1075–1084, 1998.
magnetic resonance characteristics of suspected brain infarction in 102. Gould MK, Maclean CC, Kuschner WG, et al.: Accuracy of posi-
40 dogs, J Vet Intern Med 20:311–321, 2006. tron emission tomography for diagnosis of pulmonary nodules and
80. Sutherland-Smith J, King R, Faissler D, et al.: Magnetic resonance mass lesions: a meta-analysis, J Am Med Aassoc 285:914–924, 2001.
imaging apparent diffusion coefficients for histologically confirmed 103. Schöder H, Yeung HWD: Positron emission imaging of head
intracranial lesions in dogs, Vet Radiol Ultrasound 52:142–148, and neck cancer, including thyroid carcinoma, Semin Nucl Med
2011. 34:180–197, 2004.
81. Lin C, Luciani A, Itti E, et al.: Whole-body diffusion-weighted 104. Lapela M, Eigtved A, Jyrkkiö S, et al.: Experience in qualitative
magnetic resonance imaging with apparent diffusion coefficient and quantitative FDG PET in follow-up of patients with suspected
mapping for staging patients with diffuse large B-cell lymphoma, recurrence from head and neck cancer, Eur J Cancer 36:858–867,
Eur Radiol 20:2027–2038, 2010. 2000.
82. Kraft S, Randall E, Wilhelm M: Development of a whole body 105. Seiler SMF, Baumgartner C, Hirschberger J, et al.: Comparative
magnetic resonance imaging protocol in normal dogs and canine oncology: evaluation of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)
cancer patients, Vet Radiol 48:212–220, 2007. positron emission tomography/computed tomography (PET/CT)
83. Bratton AK, Nykamp SG, Gibson T: Evaluation of hepatic contrast for the staging of dogs with malignant tumorsl, PLoS ONE 10:
enhancement with a hepatocyte-specific magnetic resonance imag- e0127800, 2015.
ing contrast agent (gadoxetic acid) in healthy dogs, Am J Vet Res 106. Randall EK, Kraft SL, Yoshikawa H, et al.: Evaluation of 18F-FDG
76:224–230, 2015. PET/CT as a diagnostic imaging and staging tool for feline oral
84. Constant C, Hecht S, Craig LE, et al.: Gadoxetate disodium squamous cell carcinoma, Vet Comp Oncol 14:28–38, 2016.
(GD-EOB-DTPA) contrast enhanced magnetic resonance imag- 107. Hansen AE, McEvoy F, Engelholm SA, et al.: FDG PET/CT imag-
ing characteristics of hepatocellular carcinoma in dogs, Vet Radiol ing in canine cancer patients, Vet Radiol Ultrasound 52:201–206,
Ultrasound 57:594–600, 2016. 2011.
85. Louvet A, Duconseille AC: Feasibility for detecting liver metastases 108. Leblanc AK, Jakoby BW, Daniel GB: 18FDG‐PET Imaging in
in dogs using gadobenate dimeglumine-enhanced magnetic reso- canine lymphoma and cutaneous mast cell tumor, Vet Radiol Ultra-
nance imaging, Vet Radiol Ultrasound 56:286–295, 2015. sound 50:215–223, 2009.
86. Suh CH, Kim KW, Kim GY, et al.: The diagnostic value of Gd- 109. Leblanc AK, Miller AN, Galyon GD, et al.: Preliminary evaluation
EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: of serial 18FDG-PET/CT to assess response to toceranib phos-
a systematic review and meta-analysis, Eur Radiol 25:950–960, phate therapy in canine cancer, Vet Radiol Ultrasound 53:348–357,
2014. 2012.
87. Kanematsu M, Kondo H, Goshima S, et al.: Imaging liver metasta- 110. Kim J, Kwon SY, Cena R, et al.: CT and PET-CT of a dog with
ses: review and update, Eur J Radiol 58:217–228, 2006. multiple pulmonary adenocarcinoma, J Vet Med Sci 76:615–620,
88. Jankowski MK, Steyn PF, Lana SE, et al.: Nuclear scanning with 2014.
99mTc-HDP for the initial evaluation of osseous metastasis in 111. Ballegeer EA, Forrest LJ, Jeraj R, et al.: PET/CT following inten-
canine osteosarcoma, Vet Comp Oncol 1:152–158, 2003. sity-modulated radiation therapy for primary lung tumor in a dog,
89. Forrest LJ, Thrall DE: Bone scintigraphy for metastasis detection in Vet Radiol Ultrasound 47:228–233, 2006.
canine osteosarcoma, Vet Radiol Ultrasound 35:124–130, 1994. 112. LeBlanc AK, Jakoby BW, Townsend DW, et al.: 18FDG-PET
90. Rybak LD, Rosenthal DI: Radiological imaging for the diagnosis of imaging in canine lymphoma and cutaneous mast cell tumor, Vet
bone metastases, Q J Nucl Med 45:53–64, 2001. Radiol Ultrasound 50:215–223, 2009.
91. Peterson ME, Broome MR: Thyroid scintigraphy findings in 113. Anderson CL, MacKay CS, Roberts GD, et al.: Comparison of
2096 cats with hyperthyroidism, Vet Radiol Ultrasound 56: abdominal ultrasound and magnetic resonance imaging for detec-
84–95, 2014. tion of abdominal lymphadenopathy in dogs with metastatic
92. Berry CR, Daniel GB: Textbook of veterinary nuclear medicine, ed 2, apocrine gland adenocarcinoma of the anal sac, Vet Comp Oncol
Knoxville, 2006, American College of Veterinary Radiology. 13:98–105, 2015.
93. Ragni RA, Moore AH: Kidney surgery, Companion Anim 18:16– 114. Ballegeer EA, Adams WM, Dubielzig RR: Computed tomography
24, 2013. characteristics of canine tracheobronchial lymph node metastasis,
94. Workman RB, Coleman RE: PET/CT Essentials for clinical practice, Vet Radiol 51:397–403, 2010.
New York, 2006, Springer-Verlag. 115. Iwasaki R, Murakami M, Kawabe M, et al.: Metastatic diagnosis
95. Grant FD, Fahey FH, Packard AB, et al.: Skeletal PET with of canine sternal lymph nodes using computed tomography char-
18F-fluoride: applying new technology to an old tracer, J Nucl Med acteristics: a retrospective cross-sectional study, Vet Comp Oncol
49:68–78, 2008. 68:536–538, 2017.
96. Spriet M, Espinosa P, Kyme AZ, et al.: Positron emission tomogra- 116. De Swarte M, Alexander K, Rannou B, et al.: Comparison of sono-
phy of the equine distal limb: exploratory study, Vet Radiol Ultra- graphic features of benign and neoplastic deep lymph nodes in
sound 57:630–638, 2016. dogs, Vet Radiol Ultrasound 52:451–456, 2011.
97. Valdés-Martínez A, Kraft SL, Brundage CM, et al.: Assessment of 117. Nyman HT, Kristensen AT: Characterization of normal and
blood pool, soft tissue, and skeletal uptake of sodium fluoride F 18 abnormal canine superficial lymph nodes using gray-scale B-mode,
with positron emission tomography-computed tomography in four color flow mapping, power, and spectral Doppler ultrasonography:
clinically normal dogs, Am J Vet Res 73:1589–1595, 2012. a multivariate study, Vet Radiol 46:404–410, 2005.